Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of OC + GSK1265744 in Healthy Females
NCT02159131Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cabotegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Primary endpoint: Plasma Area Under the Curve (AUC[0-tau]) for Levonorgestrel and Ethinyl Estradiol at Day 21. Started Aug 2014; status: completed.
02
Drugs
cabotegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02159131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02159131.